|4Jan 3, 5:42 PM ET

Marshall Dennis E 4

4 · BIOLARGO, INC. · Filed Jan 3, 2024

Insider Transaction Report

Form 4
Period: 2023-12-31
Transactions
  • Award

    Option to Purchase Common Stock

    2023-12-31+111,6074,108,116 total
    Exercise: $0.17From: 2023-12-31Exp: 2033-12-31Common Stock (111,607 underlying)
  • Award

    Option to Purchase Common Stock

    2023-12-31+133,9294,152,045 total
    Exercise: $0.17From: 2023-12-31Exp: 2033-12-31Common Stock (133,929 underlying)
Footnotes (3)
  • [F1]This Option was issued to Reporting Person as payment for $18,750 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.
  • [F2]This Option was granted to Reporting Person to replace an option to purchase 90,000 shares that had been issued December 31, 2013 to compensate Reporting Person for services to the Issuer and had recently expired unexercised due to a discrepancy between the original exercise price and current Issuer stock price, pursuant to plan adopted by the Issuer's Compensation Committee.
  • [F3]Total reflects the expiration of options to purchase 90,000 shares that expired on December 31, 2023.

Documents

2 files